The myostatin-activin-SMAD cascade has been shown to activate FOXO3a, a crucial activator of muscle-atrophy-related gene expression (Mathew, 2011); ActRIIB antagonism suffices to revert muscle wasting and prolong survival in animals affected by cancer cachexia (Zhou et al., 2010). The gene discussed is ACVR2B; the disease is cancer.